Solar and wind power have been dismissed as too expensive, too inefficient, too unreliable or too ugly. In recent years, however, the wind has changed direction. Even if these criticisms were once true, they no longer are. But there is a counterblast that may yet force the wind to do another U-turn: green energy is very resource-hungry.
Building an offshore wind plant, for example, consumes 13 times as many minerals as erecting a gas-fired power plant of equal capacity. According to the International Energy Agency, to hit net zero by , the world will have to increase its production of minerals such as lithium, copper, nickel and the rare earth elements…. That is better than the 2. First, there was a week of flashy announcements from world leaders, now there is a week of intense expectation as negotiators attempt to draw up a consensus statement that every participating country will agree to.
This huge task was under way as New Scientist went to press, but there were four announcements of real significance amid the flurry of pledges from the first week. How can I contact the author of an article? A list of contact information for New Scientist is located here. Remember that the easiest way to contact companies mentioned in the text of an article is to call directory enquiries for a number, as our journalists are very busy and may take some time to get back to you with information.
Likewise, reports or articles referred to in news stories are best obtained from the publisher of the individual report or article, rather than New Scientist , which is simply writing about the report. Where should I send the information? Press releases should be sent to our news desk. We regret that due to the number of press releases received, a personal reply will not usually be possible.
How do I get in touch with an expert on my illness? The staff at New Scientist magazine are not medical experts, and as such we are not equipped to advise on medical matters. If you have questions about your illness, then you should approach your family doctor, who will be best placed to advise you about your own condition.
One of your articles mentioned a product I would like to buy, how can I get in touch with the supplier? If an article mentions a product, the article itself will usually contain all the necessary information to track down the research team or company developing the product, and online articles will often have a link.
It is unlikely that we have any further details we would be able to disclose. What are the terms and conditions? Letters to the Editor are for publication. Include your full postal address and telephone number, and a reference issue, page number, title to articles.
We reserve the right to edit letters. New Scientist reserves the right to use any submissions sent to the letters column of New Scientist magazine, in any other format. If you want to send a private message about the content of an article, you should find the appropriate department here.
Due to the volume of correspondence we receive, we regret that we cannot guarantee a reply. What is a free New Scientist account? A free New Scientist account gives you access to newscientist. If you have a New Scientist account, you can log in to manage your account settings and newsletter preferences.
Create a free New Scientist account here. How do I create a New Scientist account? You can create an account here. What is unlimited online access to newscientist. In , we added content from the magazine to newscientist. This content was previously available in a separate archive and includes the very best articles from New Scientist dating back to How do I get unlimited online access? Unlimited online access for individual subscribers If you subscribe to New Scientist you have unlimited access to newscientist.
This includes access to an archive of content spanning more than 30 years. If you already have a subscription but do not have a password, please activate your subscription now. Unfortunately, subscriptions to the digital edition from iTunes, Google Play or Zinio do not include full access to newscientist. Contact us for additional information. Unlimited online access for Athens users You can log in using your Athens authentication details if you have subscribed to New Scientist via Eduserv.
If you are having problems logging via this page, please contact your Athens Administrator in the first instance. We have no plans to implement Shibboleth or provide federated access at present. Customers moving from Athens to the Access Federation may wish to consider another access route, such as an Educational access or Corporate access licence with IP authentication, or renegotiating Athens access with Eduserv. This does not require cookies, and once you have a log in, it is straightforward to link your free account to your subscription.
Log in and activate your subscription. Unlimited online access is available for free to New Scientist subscribers. If you are not a subscriber, then subscribe now through the online subscription centre. Subscribe to the weekly print magazine, the New Scientist app or both to get unlimited access to newscientist. If you are a subscriber, then simply log in with your email address and password when prompted. We will need to be able place a cookie on your computer to maintain your unlimited online access.
If you are experiencing technical difficulties staying logged in, please check here for further information. Can I subscribe to unlimited online access only and not the print magazine or New Scientist app? We do not currently offer online access only.
Online access is included within a Print or Digital subscription. Why do I have to log in every time I click on a new article? When logging in to newscientist. This will keep you logged in to the website. This will help us answer key business questions and enhance our ability to harness new tools and technologies, such as AI and machine learning, both now and in the future.
We are also mobilising a team of data scientists, bioinformaticians, data engineers and machine learning experts from across the company to ensure we are collecting, organising and using the right data in the best way. Rapid developments in AI technology have brought us in to uncharted territory, and companies and regulators must work together to meet the new challenges posed.
Our principles will empower us and our partners to navigate this new environment safely and effectively. By encouraging innovation and evolution while maintaining our values, they provide a long-term ethical foundation to uphold our AI governance.
During , we engaged a diverse range of experts both inside and outside AstraZeneca to develop principles for ethical data and AI, aligned with our Code of ethics and values. These values work for patients and employees and enable AstraZeneca to make a positive contribution to society. Whatever your role, everyone in Data and AI makes a big contribution to our purpose, and our enterprise-wide transformation.
Your email address will only be used to provide you with services from AstraZeneca that you requested. You can opt out for email subscriptions at any time. Your personal information will not be provided to any third party without your permission. If you believe in the power of what science can do, join us in our endeavour to push the boundaries of science to deliver life-changing medicines.
We know that however innovative our science, however effective our medicines and delivery, to achieve all we want to achieve, we cannot do it alone. You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.
AstraZeneca provides this link as a service to website visitors. AstraZeneca is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit. Important notice for users You are about to access AstraZeneca historic archive material. Any reference in these archives to AstraZeneca products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data.
Please refer to your approved national product label SmPC for current product information. I have read this warning and will not be using any of the contained product information for clinical purposes. Search Menu. Search Search Search Close. At AstraZeneca we harness data and technology to maximise time for the discovery and delivery of potential new medicines.
Learn more about Jim Weatherall. Turning data in to knowledge. Read more about how we are using AI to better understand disease. Predicting what molecules to make next and how to make them. Using AI for fast, accurate image analysis. Accelerating clinical trials through data science and AI. Building the right data backbone. Read more about our data and AI ethical principles. Pushing the boundaries of science through AI expertise.
Our leading scientists are using AI to help redefine medical science in the quest for new and better ways to discover, test and accelerate the potential medicines of tomorrow.
0コメント